Physician profile
Eric V Hastriter
NPI 1740381920
$478.39
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.13 · 2020: $51.15 · 2021: $22.32 · 2022: $140 · 2023: $68.80 · 2024: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $114.33 | 2024 | Vyepti |
| Abbvie INC. | $102.02 | 2022 | |
| Ucb, INC. | $90.50 | 2020-2023 | Fintepla, Briviact |
| Teva Pharmaceuticals USA, INC. | $64.14 | 2019 | |
| Azurity Pharmaceuticals, INC. | $37.64 | 2022 | |
| Alexion Pharmaceuticals, INC. | $21.98 | 2023 | Koselugo |
| Mallinckrodt Enterprises LLC | $17.99 | 2019 | |
| Piramal Critical Care | $14.89 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.07 | 2020 | |
| Travere Therapeutics, INC. | $0.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hastriter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.